BAB INC (BABB) Financials

BABB

Trailing 12 months to August 31, 2026

Revenue $3.5M +7.7% YoY

Net Income $654K +17.1% YoY

EPS (Diluted) Not reported for the trailing 12 months

Operating Cash Flow $690K +2.3% YoY

Market Cap $5.9M as of Oct 16, 2026

Price / Sales 1.7x on $3.5M revenue, trailing 12 months to August 31, 2026

Price / Earnings 9.0x on $654K net income, trailing 12 months to August 31, 2026

Price / Book 1.6x on $3.7M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Aug 31, 2026 Reported Oct 13, 2026 Currency USD FYE November

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BABB SEC filings page.

BAB INC (BABB) reported $3.5M in revenue over the twelve months to Aug 31, 2026, up 7.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BABB FY2025 2026-10-03

BAB, Inc. turns a modest sales base into higher operating margins, but latest-year cash generation lagged reported profit while shareholder distributions continued.

The earnings-to-cash relationship reversed: operating cash flow exceeded net income in the prior year but reached only 74.1% of latest-year net income. Because dividends of $436K exceeded operating cash flow of $414K, the latest distribution depended on resources beyond that year's operating inflow rather than being fully funded by it.

As sales declined in FY2025, operating margin widened from 18.8% to 21.0%. That points to cost absorption or revenue mix improving faster than volume, although the reported lines do not identify which mechanism drove the change.

Short-term liquidity strengthened: the current ratio reached 4.3x as current liabilities fell year over year, giving the business more reported flexibility against near-term obligations. Debt-to-equity also declined from 0.45x to 0.38x, so the liquidity improvement coincided with a less leveraged balance-sheet structure.

Financial Health Signals

Financial health score not available

BAB INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

1.23

BAB INC scores 1.23, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($5.9M) relative to total liabilities ($1.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/7

BAB INC passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

0.74x

For every $1 of reported earnings, BAB INC generates $0.74 in operating cash flow ($414K OCF vs $559K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$908K

YoY+18.1%

QoQ+13.0%

5Y CAGR+2.9%

10Y CAGR+4.0%

BAB INC generated $908K in revenue in Q3 2026. This represents an increase of 18.1% from the same quarter a year earlier. Against the prior quarter it is up 13.0%.

EBITDA

$302K

YoY+37.1%

QoQ+16.0%

5Y CAGR+8.6%

10Y CAGR+5.9%

BAB INC's EBITDA was $302K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 37.1% from the same quarter a year earlier. Against the prior quarter it is up 16.0%.

Net Income

$227K

YoY+35.6%

QoQ+21.7%

5Y CAGR+11.4%

10Y CAGR+3.2%

BAB INC reported $227K in net income in Q3 2026. This represents an increase of 35.6% from the same quarter a year earlier. Against the prior quarter it is up 21.7%.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt

$2.4M

YoY+18.4%

QoQ+8.5%

5Y CAGR+10.5%

10Y CAGR+11.4%

BAB INC held $2.4M in cash as of Q3 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.01

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

10Y CAGR0.0%

BAB INC paid $0.01 per share in dividends in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

10Y CAGR0.0%

BAB INC had 7M shares outstanding in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Margins & Returns

Operating Margin

33.2%

YoY+4.7pp

QoQ+2.4pp

5Y change+8.1pp

10Y change+6.3pp

BAB INC's operating margin was 33.2% in Q3 2026, reflecting core business profitability. This is up 4.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.

Net Margin

25.1%

YoY+3.2pp

QoQ+1.8pp

5Y change+8.2pp

10Y change-1.8pp

BAB INC's net profit margin was 25.1% in Q3 2026, showing the share of revenue converted to profit. This is up 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Return on Equity

6.1%

YoY+1.2pp

QoQ+0.9pp

5Y change+1.6pp

10Y change+0.2pp

BAB INC's ROE was 6.1% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

BABB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BABB quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.5M	$3.4M-3.0%	$3.5M+1.0%	$3.5M+6.8%	$3.3M+7.0%	$3.1M+29.5%	$2.4M-22.7%	$3.1M+41.2%	$2.2M-2.1%	$2.2M-6.9%	$2.4M+7.7%	$2.2M-12.6%	$2.5M+3.4%	$2.5M-8.4%	$2.7M-11.5%	$3.0M
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$924K-11.0%	-$832K
Operating Income	$856K	$722K+8.5%	$665K+8.2%	$615K+1.2%	$608K+12.2%	$542K+132.1%	$233K-50.7%	$473K-11.9%	$538K+17.0%	$460K0.0%	$460K+346.3%	$103K-80.9%	$538K+39.6%	$385K-12.1%	$439K+8.6%	$404K
EBITDA	N/A	$726K+8.5%	$669K+8.2%	$619K+1.0%	$612K+12.0%	$547K+130.8%	$237K-50.2%	$476K-11.8%	$539K+14.4%	$471K-1.8%	$480K+299.4%	$120K-78.4%	$556K+38.0%	$403K-11.9%	$457K+6.4%	$430K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1K-53.6%	$3K-33.8%	$4K-24.4%	$6K-18.9%	$7K-15.3%	$8K
Income Tax	$256K	$221K+7.2%	$206K+12.7%	$183K+3.9%	$176K+47.8%	$119K-60.3%	$300K+1099.8%	$25K-16.7%	$30K+445.5%	$6K-42.1%	$10K+211.8%	-$9K-137.9%	$22K-25.4%	$30K+100.4%	$15K+200.0%	$5K
Net Income	$654K	$559K+6.4%	$525K+12.4%	$467K+8.2%	$432K-33.7%	$651K+1084.0%	-$66K-114.7%	$449K-11.6%	$508K+11.8%	$454K+1.1%	$449K+307.2%	$110K-78.4%	$512K+46.0%	$351K-16.4%	$419K+6.3%	$394K
EPS (Basic)	N/A	$0.08+14.3%	$0.07+16.7%	$0.060.0%	$0.06-33.3%	$0.09	N/A	N/A	N/A	N/A	$0.06+200.0%	$0.02-71.4%	$0.07+40.0%	$0.05-16.7%	$0.06+20.0%	$0.05
EPS (Diluted)	—	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0.06+200.0%	$0.02-71.4%	$0.07+40.0%	$0.05-16.7%	$0.06+20.0%	$0.05
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	7M0.0%	7M0.0%	7M-0.1%	7M0.0%	7M0.0%	7M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$908K+18.1%	$804K-0.6%	$724K-4.4%	$1.1M+15.8%	$769K-11.9%	$808K-8.4%	$757K-9.4%	$954K-0.9%
Operating Income	$301K+37.7%	$247K+23.2%	$153K+3.8%	$155K+1.9%	$219K+6.8%	$201K+7.7%	$147K+20.7%	$152K-13.4%
EBITDA	$302K+37.1%	$260K+28.8%	$154K+4.0%	$156K+2.1%	$220K+6.8%	$202K+7.6%	$148K+20.5%	$153K-13.2%
Income Tax	$87K+32.2%	$73K+21.4%	$47K+2.0%	$49K+4.2%	$66K+5.3%	$60K+4.7%	$46K+17.4%	$47K-10.4%
Net Income	$227K+35.6%	$187K+21.1%	$119K+2.5%	$121K+0.1%	$168K+4.6%	$154K+5.9%	$116K+18.0%	$121K-12.4%
EPS (Basic)	$0.03+50.0%	$0.03+50.0%	$0.020.0%	$0.02+100.0%	$0.020.0%	$0.020.0%	$0.02+100.0%	$0.010.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Interest Expense, EPS (Diluted), Diluted Shares (Avg).

BABB Balance Sheet

BABB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$4.8M-1.3%	$4.8M+12.7%	$4.3M+0.1%	$4.3M-3.7%	$4.5M+8.9%	$4.1M-3.2%	$4.2M-3.1%	$4.4M+12.9%	$3.9M-0.1%	$3.9M+5.0%	$3.7M+0.4%	$3.7M-2.6%	$3.8M-7.7%	$4.1M0.0%	$4.1M
Current Assets	$2.5M-0.4%	$2.5M+11.0%	$2.3M+5.0%	$2.2M-4.8%	$2.3M+25.1%	$1.8M+8.1%	$1.7M+0.1%	$1.7M+0.7%	$1.7M-0.2%	$1.7M+13.6%	$1.5M+2.0%	$1.4M-5.6%	$1.5M-16.8%	$1.8M+0.8%	$1.8M
Cash & Equivalents	$2.2M-1.1%	$2.2M+15.3%	$1.9M+16.4%	$1.6M+11.0%	$1.5M+18.3%	$1.2M+12.9%	$1.1M+2.8%	$1.1M+34.4%	$793K-12.6%	$907K+8.3%	$837K+18.0%	$710K+3.8%	$684K-45.6%	$1.3M+1.6%	$1.2M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$58K-17.9%	$70K-2.2%	$72K-3.1%	$74K-19.0%	$91K+45.0%	$63K-5.8%	$67K-14.3%	$78K+38.5%	$56K+10.8%	$51K-32.3%	$75K-59.0%	$183K+33.3%	$137K+59.5%	$86K-23.4%	$112K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.5M0.0%	$1.5M	N/A	N/A	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M
Total Liabilities	$1.3M-12.4%	$1.5M+34.2%	$1.1M-8.2%	$1.2M-20.1%	$1.5M+0.3%	$1.5M+17.0%	$1.3M-4.8%	$1.4M+34.9%	$1.0M-8.6%	$1.1M+18.1%	$938K+39.9%	$670K-20.7%	$846K-9.2%	$932K-17.6%	$1.1M
Current Liabilities	$586K-19.1%	$725K+11.9%	$648K-15.8%	$770K-29.9%	$1.1M+1.8%	$1.1M+25.3%	$860K-6.1%	$916K-9.5%	$1.0M-8.6%	$1.1M+18.1%	$938K+47.2%	$637K-18.4%	$780K-6.6%	$836K-16.9%	$1.0M
Non-Current Liabilities	$730K-6.1%	$777K+65.0%	$471K+4.7%	$450K+5.0%	$429K-3.2%	$443K+0.8%	$439K-2.2%	$449K	$0	$0	$0-100.0%	$33K-48.8%	$65K-31.8%	$96K-23.3%	$125K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$33K-48.8%	$65K-47.7%	$125K	N/A
Total Equity	$3.5M+3.7%	$3.3M0.0%	$3.3M+5.1%	$3.2M+8.4%	$2.9M+14.0%	$2.6M-12.2%	$2.9M-2.3%	$3.0M+5.1%	$2.9M+3.3%	$2.8M+0.5%	$2.8M-8.4%	$3.0M+2.6%	$2.9M-7.3%	$3.2M+6.8%	$3.0M
Retained Earnings	-$10.8M+1.1%	-$10.9M+1.5%	-$11.1M+0.9%	-$11.2M+1.2%	-$11.3M+3.1%	-$11.7M-3.1%	-$11.3M+0.1%	-$11.4M+0.5%	-$11.4M+0.8%	-$11.5M+0.1%	-$11.5M-2.2%	-$11.3M+0.7%	-$11.3M-2.1%	-$11.1M+1.8%	-$11.3M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$5.2M+4.8%	$4.9M+3.3%	$4.8M+1.3%	$4.8M-1.3%	$4.9M+2.8%	$4.8M+0.4%	$4.7M-0.2%	$4.8M+12.7%
Current Assets	$2.9M+12.0%	$2.7M+9.2%	$2.5M+5.0%	$2.5M-0.4%	$2.6M+8.9%	$2.5M+4.5%	$2.4M+3.5%	$2.5M+11.0%
Cash & Equivalents	$2.4M+18.4%	$2.2M+8.1%	$2.1M+5.2%	$2.2M-1.1%	$2.0M+5.2%	$2.0M+5.7%	$2.0M+6.0%	$2.2M+15.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$66K-17.6%	$61K-5.2%	$56K-14.0%	$58K-17.9%	$81K-1.6%	$65K-11.6%	$65K-5.2%	$70K-2.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.5M	$1.5M	$1.5M	$1.5M0.0%	N/A	N/A	N/A	$1.5M
Total Liabilities	$1.4M-3.6%	$1.4M-5.2%	$1.3M-9.2%	$1.3M-12.4%	$1.5M+0.8%	$1.5M-6.2%	$1.5M-7.5%	$1.5M+34.2%
Current Liabilities	$783K-5.3%	$719K-2.1%	$637K-11.7%	$586K-19.1%	$827K+19.4%	$734K-1.1%	$722K-6.8%	$725K+11.9%
Non-Current Liabilities	$663K-1.4%	$658K-8.3%	$691K-6.8%	$730K-6.1%	$673K-15.4%	$718K-10.8%	$742K-8.2%	$777K+65.0%
Total Equity	$3.7M+8.5%	$3.6M+7.0%	$3.4M+6.1%	$3.5M+3.7%	$3.4M+3.7%	$3.3M+3.6%	$3.2M+3.4%	$3.3M0.0%
Retained Earnings	-$10.6M+2.7%	-$10.7M+2.1%	-$10.8M+1.8%	-$10.8M+1.1%	-$10.9M+1.1%	-$11.0M+1.0%	-$11.0M+1.0%	-$10.9M+1.5%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

BABB Cash Flow Statement

BABB quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$690K	$414K-35.0%	$638K+19.3%	$534K+295.7%	$135K-81.2%	$718K+237.4%	$213K-50.7%	$432K+10.1%	$392K+50.9%	$260K-52.1%	$543K+3.2%	$526K+5.3%	$500K+993.1%	$46K-90.8%	$495K+6.7%	$464K
Depreciation & Amortization	N/A	$4K+8.7%	$4K+8.3%	$4K-14.3%	$4K-13.2%	$5K+43.6%	$4K+73.2%	$2K+70.0%	$1K-89.5%	$12K-42.8%	$20K+17.5%	$17K-4.7%	$18K+2.8%	$17K-7.6%	$19K-28.3%	$26K
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0	$0	$0	$0	$0-100.0%	$10K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3K	N/A	N/A	N/A	N/A	N/A	N/A	$11K+0.5%	$11K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$428K	N/A	N/A	N/A	N/A	N/A	N/A	$484K+6.9%	$453K
Investing Cash Flow	-$3K	-$6K+43.3%	-$10K-744.1%	-$1K	$0+100.0%	-$3K+81.0%	-$13K-43.3%	-$9K-60.5%	-$6K+48.3%	-$11K-177.7%	-$4K-25.6%	-$3K+58.1%	-$8K+3.4%	-$8K+29.3%	-$11K-36.9%	-$8K
Financing Cash Flow	-$363K	-$436K-20.0%	-$363K0.0%	-$363K-25.0%	-$291K0.0%	-$291K-365.7%	-$62K+85.7%	-$436K-20.0%	-$363K0.0%	-$363K+22.6%	-$469K-18.8%	-$395K+15.3%	-$466K+23.6%	-$610K-31.6%	-$464K-0.3%	-$462K
Dividends Paid	$363K	$436K+20.0%	$363K0.0%	$363K+25.0%	$291K0.0%	$291K0.0%	$291K-33.3%	$436K+20.0%	$363K0.0%	$363K-16.7%	$436K+20.0%	$363K-16.7%	$436K-25.0%	$581K+33.3%	$436K0.0%	$436K

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$267K+57.2%	$282K+55.6%	$182K+74.3%	-$41K-118.8%	$170K+60.5%	$181K+50.3%	$105K-45.6%	$219K+99.8%
Depreciation & Amortization	$300-72.2%	$12K+1171.0%	$1K+39.8%	$1K+21.8%	$1K+10.2%	$9810.0%	$9800.0%	$1K+20.4%
Investing Cash Flow	$0+100.0%	$0+100.0%	$0-100.0%	-$3K+73.6%	-$5K	-$2K	$5K	-$10K
Financing Cash Flow	-$73K0.0%	-$73K0.0%	-$145K+33.3%	-$73K0.0%	-$73K0.0%	-$73K0.0%	-$218K-50.0%	-$73K0.0%
Dividends Paid	$73K0.0%	$73K0.0%	$145K-33.3%	$73K0.0%	$73K0.0%	$73K0.0%	$218K+50.0%	$73K0.0%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.

BABB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BABB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	21.0%+2.2pp	18.8%+1.3pp	17.5%-1.0pp	18.5%+0.9pp	17.6%+7.8pp	9.8%-5.6pp	15.4%-9.3pp	24.7%+4.1pp	20.7%+1.4pp	19.3%+14.6pp	4.7%-16.6pp	21.2%+5.5pp	15.7%-0.7pp	16.4%+3.0pp	13.4%
Net Margin	16.3%+1.4pp	14.8%+1.5pp	13.3%+0.2pp	13.1%-8.1pp	21.2%+24.0pp	-2.8%-17.4pp	14.6%-8.7pp	23.4%+2.9pp	20.4%+1.6pp	18.8%+13.9pp	5.0%-15.2pp	20.2%+5.9pp	14.3%-1.4pp	15.7%+2.6pp	13.0%
Return on Equity	16.1%+0.4pp	15.7%+1.7pp	14.0%+0.4pp	13.6%-8.6pp	22.2%+24.8pp	-2.6%-17.9pp	15.3%-1.6pp	16.9%+1.0pp	15.9%-0.4pp	16.3%+12.3pp	4.0%-13.0pp	17.0%+5.1pp	12.0%-1.3pp	13.3%-0.1pp	13.3%
Return on Assets	11.7%+0.9pp	10.8%0.0pp	10.9%+0.8pp	10.1%-4.5pp	14.6%+16.2pp	-1.6%-12.2pp	10.6%-1.0pp	11.6%-0.1pp	11.7%+0.1pp	11.6%+8.6pp	3.0%-10.9pp	13.9%+4.6pp	9.3%-1.0pp	10.3%+0.6pp	9.6%
Current Ratio	4.26+0.8x	3.460.0x	3.49+0.7x	2.80+0.7x	2.06+0.4x	1.68-0.3x	1.95+0.1x	1.83+0.2x	1.64+0.1x	1.50-0.1x	1.56-0.7x	2.26+0.3x	1.95-0.2x	2.19+0.4x	1.80
Debt-to-Equity	0.38-0.1x	0.45+0.1x	0.340.0x	0.38-0.1x	0.52-0.1x	0.59+0.1x	0.440.0x	0.46+0.1x	0.350.0x	0.40+0.1x	0.34+0.3x	0.010.0x	0.020.0x	0.04-0.3x	0.38
Asset Turnover	0.720.0x	0.73-0.1x	0.82+0.1x	0.77+0.1x	0.69+0.1x	0.58-0.1x	0.73+0.2x	0.50-0.1x	0.570.0x	0.620.0x	0.60-0.1x	0.690.0x	0.650.0x	0.65-0.1x	0.74
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	14.0%	N/A	N/A	N/A	N/A	N/A	N/A	18.1%+3.1pp	15.0%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Margin	33.2%+4.7pp	30.8%+6.0pp	21.1%+1.7pp	14.0%-1.9pp	28.5%+5.0pp	24.8%+3.7pp	19.4%+4.8pp	15.9%-2.3pp
Net Margin	25.1%+3.2pp	23.3%+4.2pp	16.5%+1.1pp	10.9%-1.7pp	21.8%+3.4pp	19.1%+2.6pp	15.3%+3.6pp	12.6%-1.7pp
Return on Equity	6.1%+1.2pp	5.3%+0.6pp	3.5%-0.1pp	3.5%-0.1pp	4.9%0.0pp	4.7%+0.1pp	3.6%+0.5pp	3.6%-0.5pp
Return on Assets	4.4%+1.0pp	3.8%+0.6pp	2.5%0.0pp	2.5%0.0pp	3.4%+0.1pp	3.2%+0.2pp	2.5%+0.4pp	2.5%-0.7pp
Current Ratio	3.74+0.6x	3.75+0.4x	3.93+0.6x	4.26+0.8x	3.17-0.3x	3.36+0.2x	3.30+0.3x	3.460.0x
Debt-to-Equity	0.390.0x	0.390.0x	0.39-0.1x	0.38-0.1x	0.440.0x	0.440.0x	0.45-0.1x	0.45+0.1x
Asset Turnover	0.180.0x	0.160.0x	0.150.0x	0.230.0x	0.160.0x	0.170.0x	0.160.0x	0.200.0x

Not reported in any period shown, so not listed: Gross Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
BAB INC BABB	FY2025	$3.4M	$559K	16.3%	$5.9M	—
INTEGRATED BIOPHARMA INC INBP	FY2026	$43.9M	-$2.8M	-6.5%	$5.6M	—
STEAKHOLDER FOODS LTD MTTCF	FY2025	N/A	-$11.2M	N/A	$14.7M	—

Where BAB INC Ranks

Frequently Asked Questions

What is BAB INC's annual revenue?

BAB INC (BABB) reported $3.4M in total revenue for fiscal year 2025. This represents a -3.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BAB INC's revenue growing?

BAB INC (BABB) revenue declined by 3.0% year-over-year, from $3.5M to $3.4M in fiscal year 2025.

Is BAB INC profitable?

Yes, BAB INC (BABB) reported a net income of $559K in fiscal year 2025, with a net profit margin of 16.3%.

What is BAB INC's EBITDA?

BAB INC (BABB) had EBITDA of $726K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is BAB INC's operating margin?

BAB INC (BABB) had an operating margin of 21.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is BAB INC's net profit margin?

BAB INC (BABB) had a net profit margin of 16.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does BAB INC pay dividends?

Yes, BAB INC (BABB) paid $0.06 per share in dividends during fiscal year 2025.

What is BAB INC's return on equity (ROE)?

BAB INC (BABB) has a return on equity of 16.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is BAB INC's operating cash flow?

BAB INC (BABB) generated $414K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are BAB INC's total assets?

BAB INC (BABB) had $4.8M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does BAB INC have outstanding?

BAB INC (BABB) had 7M shares outstanding as of fiscal year 2025.

What is BAB INC's current ratio?

BAB INC (BABB) had a current ratio of 4.26 as of fiscal year 2025, which is generally considered healthy.

What is BAB INC's debt-to-equity ratio?

BAB INC (BABB) had a debt-to-equity ratio of 0.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is BAB INC's return on assets (ROA)?

BAB INC (BABB) had a return on assets of 11.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is BAB INC's P/E ratio?

BAB INC (BABB) trades at 9.0x earnings, its market capitalization divided by net income of $654K net income, trailing 12 months to August 31, 2026. The market capitalization is $5.9M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is BAB INC's price-to-sales ratio?

BAB INC (BABB) trades at 1.7x sales, its market capitalization divided by revenue of $3.5M revenue, trailing 12 months to August 31, 2026. The market capitalization is $5.9M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is BAB INC's Altman Z-Score?

BAB INC (BABB) has an Altman Z-Score of 1.23, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is BAB INC's Piotroski F-Score?

BAB INC (BABB) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are BAB INC's earnings high quality?

BAB INC (BABB) has an earnings quality ratio of 0.74x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.